PRIOR2: Pre-oxygenation With High-flow Nasal Cannula in Adults During Rapid Sequence Induction Anesthesia

Sponsor
Karolinska University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03516175
Collaborator
St. George's Hospital, London (Other), University College London Hospitals (Other), Poole Hospital NHS Foundation Trust (Other)
350
6
2
31.3
58.3
1.9

Study Details

Study Description

Brief Summary

It has been demonstrated that Transnasal Humidified Rapid Insufflation Ventilatory Exchange used during preoxygenation for emergency surgery is at least equally effective as preoxygenation compared to standard tight fitting mask. Data from a recent study indicates that Transnasal Humidified Rapid Insufflation Ventilatory Exchange might decrease the risk of clinically relevant desaturation below 93% of arterial oxygen saturation. The limitations with our previous study is that it was done only during office hours (Mon-Friday 8 am to 4 pm) and that the power to detect the occurrence of desaturation was too low.

Based on the above, the aim is now to conduct a clinical international multicenter study 24/7 with 450 patients and with a simplified protocol that allows the study to be done 24/7. This study is done with the aim of evaluation before implementing this novel technique of preoxygenation into clinical practice.

The general purpose of this project is to compare a the preoxygenation technique based on Transnasal Humidified Rapid Insufflation Ventilatory Exchange with traditional preoxygenation with a tight fitting mask during rapid sequence induction (RSI) intubation in patients undergoing emergency surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: High flow transnasal oxygen
  • Device: Pre oxygenation using tight fitting facemask
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
350 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pre-oxygenation With High-flow Nasal Cannula in Comparison to Standard in Adults During Rapid Sequence Induction Anesthesia- a Prospective Randomized Non-blinded International Multicenter Study
Actual Study Start Date :
Mar 21, 2018
Actual Primary Completion Date :
Oct 28, 2020
Actual Study Completion Date :
Oct 28, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Tight fitting mask

Pre oxygenation with tight facemask with 100% oxygen

Device: Pre oxygenation using tight fitting facemask
100% oxygen via a tight fitting facemask

Experimental: High flow nasal oxygen

High flow nasal oxygen that is Transnasal Humidified Rapid Insufflation Ventilatory Exchange is used for pre oxygenation

Device: High flow transnasal oxygen
High flow nasal oxygen that is Transnasal Humidified Rapid Insufflation Ventilatory Exchange
Other Names:
  • Transnasal Humidified Rapid Insufflation Ventilatory Exchange
  • Outcome Measures

    Primary Outcome Measures

    1. The number of patients that desaturates below 93% in SpO2 during pre oxygenation up to 1 minute after intubation [From start of anaesthesia until 1 minute after tracheal intubation, that is normally after 3-4 minutes after anaesthesia induction]

      The number of patients that desaturates below 93% in SpO2 during pre oxygenation up to 1 minute after intubation

    Secondary Outcome Measures

    1. Lowest SpO2 during preoxygenation using THRIVE compared to traditional pre-oxygenation from time to first anesthetic drug given up to 1 minute after intubation. [From start of anaesthesia until 1 minute after tracheal intubation, that is normally after 3-4 minutes after anaesthesia induction]

      Lowest SpO2 during preoxygenation using THRIVE compared to traditional pre-oxygenation from time to first anesthetic drug given up to 1 minute after intubation.

    2. Level of end-tidal carbon dioxide in the first breath after intubation with Transnasal Humidified Rapid Insufflation Ventilatory Exchange oxygenation compared with traditional pre-oxygenation? [At the first breath after tracheal intubation that is usually 2-4 minutes after induction of anaesthesia]

      Level of end-tidal carbon dioxide in the first breath after intubation with Transnasal Humidified Rapid Insufflation Ventilatory Exchange oxygenation compared with traditional pre-oxygenation?

    3. Level of end-tidal O2 in the first breath after intubation with Transnasal Humidified Rapid Insufflation Ventilatory Exchange oxygenation compared with traditional pre-oxygenation? [At the first breath after tracheal intubation that is usually 2-4 minutes after induction of anaesthesia]

      Level of end-tidal O2 in the first breath after intubation with Transnasal Humidified Rapid Insufflation Ventilatory Exchange oxygenation compared with traditional pre-oxygenation?

    4. Incidence of gastric regurgitation between the groups? [From start of anaesthesia until 2 minutes after tracheal intubation, that is normally after 4-5 minutes after anaesthesia induction]

      Incidence of gastric regurgitation between the groups?

    5. Difference in numbers of patients being ventilated between the two groups? [From start of anaesthesia until the patient is intubated, usually within 3-4 minutes]

      Is there a difference in the number of patients that was ventilated before intubation between the two study groups?

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Adult, >18 years old

    2. Emergency intubation where Rapid Sequence Induction is indicated

    3. Capable of understanding the study information and signing the written consent.

    Exclusion Criteria:
    1. Body Mass Index >35

    2. Pregnancy

    3. Dependency on non-invasive ventilation to maintain oxygen saturation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centralsjukhuset Karlstad Karlstad Sweden
    2 Linköping University Hospital Linköping Sweden
    3 Karolinska University Hospital Stockholm Sweden
    4 St Göran Hospital Stockholm Sweden
    5 Södersjukhuset Stockholm Sweden
    6 University Hospital of Bern Bern Switzerland

    Sponsors and Collaborators

    • Karolinska University Hospital
    • St. George's Hospital, London
    • University College London Hospitals
    • Poole Hospital NHS Foundation Trust

    Investigators

    • Principal Investigator: Malin Jonsson Fagerlund, Karolinska University Hospital and Karolinska Institutet

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Malin Jonsson Fagerlund, Senior Consultant, Associate Professor, Karolinska University Hospital
    ClinicalTrials.gov Identifier:
    NCT03516175
    Other Study ID Numbers:
    • PRIOR2
    First Posted:
    May 4, 2018
    Last Update Posted:
    Dec 10, 2020
    Last Verified:
    Dec 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 10, 2020